No Data
No Data
7 Children Given Bluebird's Skysona Developed Blood Cancer: Study
Cathie Wood's ARK Sheds Robinhood Stock, Adds to Amazon and Coinbase
CRISPR Therapeutics Deserves Its Lofty Valuation Even With Conservative Forecasts
RBC Cuts Price Target on CRISPR Therapeutics to $53 From $60, Keeps Sector Perform Rating
Cathie Wood Stocks (CRSP, SHOP, SQ) Could Actually Be Darn Good Picks
With 66% Ownership of the Shares, CRISPR Therapeutics AG (NASDAQ:CRSP) Is Heavily Dominated by Institutional Owners
No Data
No Data